128018-17-7 Usage
Description
(L)-N-BENZYLOXYCARBONYL-PROLINE-TERT BUTYLAMIDE is a synthetic compound that is widely utilized in the fields of chemical and pharmaceutical research. It is a derivative of proline, featuring a benzyl carbonyl group and a tert-butylamide group. (L)-N-BENZYLOXYCARBONYL-PROLINE-TERT BUTYLAMIDE is recognized for its potential biological activity and is frequently employed in the synthesis of peptide and protein derivatives, as well as in the development of novel drugs and pharmaceuticals. Its applications extend to the study of enzyme inhibitors and receptor ligands, and it is also used in the preparation of various organic compounds and materials within the realm of chemical synthesis.
Uses
Used in Pharmaceutical Research:
(L)-N-BENZYLOXYCARBONYL-PROLINE-TERT BUTYLAMIDE is used as a building block for the synthesis of peptide and protein derivatives, contributing to the development of new drugs and pharmaceuticals. Its role in this application is attributed to its structural properties and potential biological activity, which facilitate the creation of novel therapeutic agents.
Used in Chemical Synthesis:
In the field of chemical synthesis, (L)-N-BENZYLOXYCARBONYL-PROLINE-TERT BUTYLAMIDE is used as a key component in the preparation of various organic compounds and materials. Its unique structure and functional groups enable the synthesis of a diverse range of chemical products, further expanding its utility in research and development.
Used in Enzyme Inhibition Studies:
(L)-N-BENZYLOXYCARBONYL-PROLINE-TERT BUTYLAMIDE is employed as a potential enzyme inhibitor, allowing researchers to study its interactions with specific enzymes and explore its potential as a therapeutic agent for various diseases and conditions.
Used in Receptor Ligand Research:
(L)-N-BENZYLOXYCARBONYL-PROLINE-TERT BUTYLAMIDE is also used in the study of receptor ligands, where it can help researchers understand the binding properties and interactions between ligands and their target receptors, potentially leading to the development of new drugs with improved efficacy and selectivity.
Check Digit Verification of cas no
The CAS Registry Mumber 128018-17-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,8,0,1 and 8 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 128018-17:
(8*1)+(7*2)+(6*8)+(5*0)+(4*1)+(3*8)+(2*1)+(1*7)=107
107 % 10 = 7
So 128018-17-7 is a valid CAS Registry Number.
128018-17-7Relevant articles and documents
Optically active complexes of transition metals (RhI, RuII, CoII and NiII) with 2-aminocarbonylpyrrolidine ligands. Selective catalysts for hydrogenation of prochiral olefins
Corma, A.,Iglesias, M.,Pino, C. del,Sanchez, F.
, p. 233 - 246 (1992)
The synthesis and characterization of optically active complexes containing organic amides of the type , , , RuCl2(COD)L>, , X and X, where L = (S)-2-t-butylaminocarbony
Syntheses of HIV-protease inhibitors having a peptide moiety which binds to GP120
Asagarasu, Akira,Uchiyama, Taketo,Achiwa, Kazuo
, p. 697 - 703 (2007/10/03)
Some HIV-protease inhibitor derivatives having an N- carbomethoxycarbonyl-prolyl-phenylalanine benzyl ester (CPF) moiety as a binding site to gp120 were designed and synthesized. Almost all the compounds bearing CPF on the phenoxyacetyl group showed protease-inhibitory activity. Compounds 25a and 25b, which have the CPF moiety at the ortho- and meta- positions of the phenoxyacetyl group, respectively, had anti-HIV activity, although the others showed only protease-inhibitory activity. These results suggest that 25b binds to gp120 and inhibits HIV protease.
